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Telomerase enzymatic component hTERT shortens
long telomeres in human cells
Yun-Ling Zheng1,*, Fan Zhang2, Bing Sun1, Juan Du2, Chongkui Sun2, Jie Yuan3, Ying Wang1, Lian Tao1, Krishna Kota1,
Xuefeng Liu4, Richard Schlegel4, and Qin Yang2,*
Cancer Prevention and Control; Lombardi Comprehensive Cancer Center; Georgetown University Medical Center; Washington, DC USA; 2Cancer Biology Division; Washington
University School of Medicine; Saint Louis, MO USA; 3Medical College; Jinan University; Guangzhou, China; 4Molecular Oncology Programs; Lombardi Comprehensive Cancer
Center; Georgetown University Medical Center; Washington, DC USA
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Telomere lengths are tightly regulated within a narrow range in normal human cells. Previous studies have extensively
focused on how short telomeres are extended and have demonstrated that telomerase plays a central role in elongating
short telomeres. However, much about the molecular mechanisms of regulating excessively long telomeres is unknown.
In this report, we demonstrated that the telomerase enzymatic component, hTERT, plays a dual role in the regulation
of telomere length. It shortens excessively long telomeres and elongates short telomeres simultaneously in one cell,
maintaining the optimal telomere length at each chromosomal end for efficient protection. This novel hTERT-mediated
telomere-shortening mechanism not only exists in cancer cells, but also in primary human cells. The hTERT-mediated
telomere shortening requires hTERT’s enzymatic activity, but the telomerase RNA component, hTR, is not involved in
that process. We found that expression of hTERT increases telomeric circular DNA formation, suggesting that telomere
homologous recombination is involved in the telomere-shortening process. We further demonstrated that shelterin protein TPP1 interacts with hTERT and recruits hTERT onto the telomeres, suggesting that TPP1 might be involved in regulation of telomere shortening. This study reveals a novel function of hTERT in telomere length regulation and adds a new
element to the current molecular model of telomere length maintenance.

Introduction
Maintaining genome integrity is essential to normal cell function. For organisms with linear chromosomes, like humans, cells
need to differentiate chromosome ends from double-stranded
DNA breaks. This is achieved by the specialized nucleoprotein
structures at the end of eukaryotic chromosomes, the telomeres.1
Functional telomeres require the appropriate number of telomeric
DNA repeats, as well as the proper binding and amount of telomere-associated proteins (shelterin proteins). Telomere length is
ultimately determined by the balance between lengthening and
shortening processes, indicating that complex regulatory pathways exist and serve to keep telomere lengths from becoming too
long or too short. The best-known mechanism to lengthen short
telomeres is the enzyme telomerase, a reverse transcriptase complex that contains hTERT (the reverse transcriptase) and hTR
(the RNA template). Telomerase elongates telomeres by adding TTAGGG repeats to the ends of chromosomes.2-4 The level
of telomerase in normal human somatic tissues is insufficient
to prevent telomere shortening. Telomeres can be lengthened
through increasing telomerase activity by exogenous expression
of hTERT or hTR. Cancer cells are known to acquire indefinite

replicative capacity to escape from the normal proliferative limitations through maintaining their telomeres, either by upregulation of telomerase5 or by an alternative lengthening of telomeres
(ALT) mechanism.6-8
In contrast, very little is known about how the upper telomere length limit is maintained and how excessively long telomeres are shortened in human cells. Several mechanisms were
known to shorten telomeres: gradual telomere attrition, which
occurs as a result of end-replication limitations and nucleolytic
degradation,1,9 and rapid loss of over-lengthened telomeres by
t-loop resolution, referred to as “telomere rapid deletion”10 or
“telomere trimming”.11,12 Telomere rapid deletion in yeast cells is
a known RAD52-dependent mechanism that reduces over-elongated telomeres to the wild-type length. Telomere trimming was
first reported in human cancer cells with artificially elongated
telomeres by overexpression of hTR and was associated with elevated levels of extra-chromosomal telomere circles (t-circles).11,12
T-circles have also been detected in ALT+ (telomerase-negative)
cells9 and in cells with abnormal telomere rapid deletion.13 T-circle
generation has been shown to involve homologous recombination
proteins. However, key factors that contribute to the recognition
and initiation of the removal of excessively long telomeres in
human cells remain to be identified.
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Results
hTERT decreases the length of long telomeres and increases
the length of short telomeres in ALT+ cancer cell lines
ALT+ cancer cells are characterized by having excessively long
and heterogeneous telomere lengths across all chromosomal ends
without telomerase activity6-8. To examine the effects of hTERT
in cells with excessively long telomeres, a haemagglutinin (HA)tagged hTERT was ectopically expressed in U2OS, an osteosarcoma cell line with high ALT activity (Table 1; Fig. S1). Telomere
length (TL) at each of the chromosomal ends was measured by
telomere fluorescent in situ hybridization (T-FISH) as previously
described14 and compared between hTERT-expressing cells and
vector control cells. Dramatic decrease in the average telomere
length (Avg_TL) per telomere was observed in U2OS–hTERT

cells compared with that in U2OS–vector control cells (6237 vs.
2314, P < 0.001; Table 1; Fig. 1A and B; Fig. S2A). Significant
decreases in the telomere length variation (TLV), defined as coefficient of variation (CV%) of all measured telomeres, were
observed (76.9 vs. 61.1, P < 0.001; Table 1). The frequency of
excessively long telomeres, defined as TL > 3× average TL for a
given cell type, were also seen (average 34 per cell in vector control cells vs. 0.4 per cell in hTERT-expressing cells, P < 0.001).
Correlation analysis revealed a strong inverse correlation between
the lengths of TL at each chromosomal end in vector control
cells and the percentage TL change at the corresponding chromosomal end of U2OS–hTERT cells (r = −0.91, P < 0.001;
Fig. S3A). The most striking observation is the significant TL
shortening at most of chromosomal ends in U2OS-hTERT cells
compared with those in U2OS–vector control cells (Fig. 1A
and B). No significant increases in TL were observed for any of
the chromosomal ends. In addition, telomere restricted fragment
(TRF) analysis verified these results, as there was a significant
decrease in telomere length upon hTERT expression in U2OS
cells (Fig. S3B). These data suggested that the dominant effect of
hTERT expression in U2OS cells was shortening the excessively
long telomeres.
We further examined specific chromosome ends possessing
long or short TL. In U2OS cells, there is one normal X chromosome. Its long arm (Xq) has the shortest telomere length, while its
short arm (Xp) has an excessively long telomere (Fig. 1B). We found
that expression of hTERT significantly decreased the average TL
on Xp (9825 vs. 3141, P < 0.001), while it had no significant effect
on the TL of Xq (1480 vs. 1747, P = 0.49; Table 1; Fig. 1A and B),

Table 1. Effect of hTERT overexpressing on telomere length

Cell line, passage #

Telomerase

Avg_TL

Activity*

Overall

Avg_TL
TLV

Chromosome specific
Xp

Xq

U2OS-vector, p3

1

6237 ± 968

76.9 ± 6.0

9825 ± 3931

1480 ± 1853

U2OS-hTERT, p3

6.5

2314 ± 710

61.1 ± 10.4

3141 ± 1408

1747 ± 1021

<0.001

<0.001

<0.001

0.49

11p

11q

P value

SAOS2-vector, p4

1

1535 ± 305

130.5 ± 34.2

1404 ± 1257

20207 ± 7358

SAOS2-hTERT, p4

8.1

3236 ± 454

75.4 ± 6.9

2957 ± 2317

5168 ± 3121

<0.001

<0.001

<0.001

<0.001

10q

19p

P value

IMR90- vector, p3

1

2067 ± 219

83.4 ± 9.3

2878 ± 2093

849 ± 611

IMR90- hTERT, p3

8

2586 ± 341

76.6 ± 6.9

2372 ± 1937

1440 ± 1490

<0.001

<0.001

0.030

<0.001

Xp

21q

P value

WI38- vector, p3

1

1682 ± 295

99.7 ± 11.0

2392 ± 2396

898 ± 982

WI38-hTERT, p3

7.2

1781 ± 364

88.6 ± 10.5

1364 ± 1387

1196 ± 1274

0.26

<0.001

0.005

0.029

P value

#
Passage after hTERT or empty vector transfection. *Telomerase activity measured by TRAP assay and expressed as fold change relative to vector control.
Avg_TL is the average telomere length per telomere, expressed as fluorescent intensity unites. TLV, telomere length variation (CV%); mean ± SD were
reported values in the table. P values were based on 2-sided Student t test.
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In the present study, we revealed that hTERT plays a key role
in shortening excessively long telomeres. We analyzed single telomere alteration at each chromosomal end and demonstrated that
telomerase enzymatic component hTERT shortens excessively
long telomeres and elongates short telomeres simultaneously in
one cell. We found that this hTERT-mediated telomere-shortening process commonly exists in different types of human cells
including normal primary human cells and cancer cell lines. The
hTERT-mediated telomere shortening removes large segments of
telomere DNA rapidly without inducing telomere dysfunctional
foci or affecting cell proliferation; thus, it is mechanistically distinct from telomere rapid deletion.

Figure 1. Expression of hTERT shortens long telomeres and elongates short telomeres in ALT+ cancer cells. Empty
vector, WT or mutant hTERT, or hTR was expressed in ALT+ U2OS cells (A–D), SAOS2 cells (E–H), or a hTR-negative cell
line WI38-VA13 (I and J). Metaphase spreads were prepared and hybridized with a Cy3 (red) telomere PNA probe and
FITC (green) label chromosome-specific centromere probes. Thirty cells were analyzed per cell line, and representative metaphase images were displayed. (A) U2OS-vector, (B) U2OS-hTERT, (C) U2OS-mutant-hTERT, (D) U2OS-hTR;
Amplified chromosome X was showed in the upper-right corner. (E) SAOS2-vector, (F) SAOS2-hTERT, (G) SAOS2mutant-hTERT, (H) SAOS2-hTR; amplified chromosome 11 is shown in the upper right corner. (I) WI-38-VA13 vector,
and (J) WI-38-VA13-hTERT.
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indicating that hTERT
selectively shortens long
telomeres in U2OS cells.
h T E R T- m e d i a t e d
shortening of excessively
long telomeres was confirmed in another ALT+
cancer cell line, SAOS2.
This cell line has low ALT
activity and is characterized by having short TL
at the most chromosomal
ends and one excessively
long telomere on the long
arm (q) of one of chromosomes 11 (Fig. 1E).
Expressing hTERT in
SAOS2 induced a significant decrease in TLV and
increase in the average
TL per telomere (Table 1;
Fig. S2B). Correlation
analysis revealed a strong
inverse
correlation
between the lengths of TL
at each chromosomal end
in vector control cells and
the percentage TL change
at the corresponding chromosomal end of SAOS2–
hTERT cells (r = -0.84,
P < 0.001; Fig. S3C). Most
importantly, we found
that expression of hTERT
significantly shortened TL
on 11q (−56%) and elongated TL on 11p (+248%;
Table 1; Fig. 1E and F),
confirming that hTERT
selectively shortens long
telomeres and elongates
short telomeres in ALT+
cancer cells. Moreover,
indirect immunofluorescence and telomere FISH
displayed the localization
of hTERT at those telomeres with high signal
intensity, suggesting that
hTERT can be recruited to
long telomeres (Fig. S4).
Together, these data
indicate that hTERT
plays dual roles in telomere length regulation by
shortening excessively long

significantly shortened in hTERT-expressing cells compared
with that in control cells (-18%, P = 0.03; Table 1), while telomere length at the chromosomal end possessing the shortest telomere (19p) showed significant elongation in hTERT-expressing
cells compared with that in controls (+70%, P < 0.001; Table 1).
In IMR90 cells, 6 out of 46 (13%) chromosomal ends showed
shortened average TL in IMR90-hTERT cells (Fig. 2A).
Similar results were obtained with another primary human
fibroblast cells (WI38), showing significant decrease in TLV
across all chromosomal ends (Table 1; Fig. 2D–F) in hTERTexpressing cells compared with control cells and strong inverse
correlation between the lengths of TL at each chromosomal
end in vector control cells and percentage TL change at the
corresponding chromosomal end of hTERT-expressing cells
(r = −0.66, P < 0.001; Fig. 2D). A significant decrease (−43%)
in average TL at Xp (longest telomere in WI38) and an increase
(+51%) in average TL at 21q (the shortest telomere in WI38)
were also observed (Table 1) upon expressing hTERT. Fifteen
out of 46 (33%) chromosomal ends showed shortened average
telomere lengths in WI38-hTERT cells (Fig. 2D). These data
suggested that hTERT plays a dual role in the regulation of telomere length by shortening the long telomeres and extending the
short telomeres in normal human fibroblasts.
Upregulation of endogenous hTERT maintains small TLV
in primary epithelia cells
Fibroblast feeder cells, in combination with a Rho kinase
inhibitor, have been shown to immortalize human primary
epithelia cells that retained a normal karyotype and remained

Table 2. Effect of endogenous hTERT on telomere length in primary and cancer cells
hTERT mRNA
fold change*

Avg_TL

GUMC001-PD6

9.4

1879 ± 255

GUMC001-PD24

9.0

GUMC001-PD48

Cell-PD

overall

TLV

% of telomeres per cell
short

long

84.9 ± 9.5

10.2 ± 4.1

3.0 ± 2.1

2130 ± 298^

77.2 ± 10.1^

7.0 ± 3.6^

2.2 ± 1.9

9.0

1887 ± 283

86.0 ± 7.5

8.0 ± 4.0^

3.3 ± 2.4

IMR90-PD10

1.0

2067 ± 219

83.4 ± 9.3

7.17 ± 3.2

2.6 ± 1.3

IMR90-PD20

1.0

1580 ± 255^

100.4 ± 10.9^

14.3 ± 4.9^

4.9 ± 3.1^

Prostate epithelial cells

Fibroblast cells

IMR90-PD42

0.8

1320 ± 262^

112.0 ± 12.4^

21.6 ± 6.1^

6.2 ± 3.2^

IMR90-PD60†

0.9

1203 ± 242^

124.8 ± 23.2^

19.8 ± 6.3^

7.8 ± 4.8^

MDA231-vector

10

1088 ± 201

79.9 ± 8.0

9.4 ± 3.7

2.1 ± 1.4

MDA231+sh-hTERT

3

813 ± 263

88.2 ± 10.7

12.7 ± 5.3

3.9 ± 4.6

<0.001

0.002

0.01

0.05

Telomerase + cancer cell lines

P value
HT1080-vector

10

688 ± 164

93.6 ± 10.5

16.5 ± 6.9

4.4 ± 3.9

HT1080+sh-hTERT

2

525 ± 146

113.6 ± 9.1

20.2 ± 5.6

7.2 ± 4.6

<0.001

<0.001

0.03

0.02

P value

*Human primary karatinocytes was used as a reference to calculate hTERT mRNA fold change. Avg_TL is the average telomere length in fluorescence intensity units. TLV, telomere length variation (CV%); mean ± SD were reported values in the table. ^Significantly different from earliest passage cells (P < 0.05).
†Pre-senescent cell, only 14 metaphase cells were available for analysis. Short, very short telomeres, TL < 10% of the average TL. Long, very long telomeres,
TL > 3 times of the average TL.
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telomeres and elongating short telomeres, thus maintaining optimal telomere length at each of the chromosomal ends for efficient
protection. The data also indicate that the switch between the 2
opposite hTERT functions is dictated by the length of the telomere at a specific chromosomal end.
Expression of hTERT in human primary fibroblasts shortens long telomeres and elongates short telomeres
Wild-type hTERT was overexpressed in IMR90 (primary
human fibroblasts) at population doubling (PD) 10, and increased
telomerase activity and hTERT expression were confirmed by the
qRT-PCR, western blot analysis and the TRAP assay (Table 1;
Fig. S1). Cells were harvested at passage 3 after hTERT transfection, following a standard cytogenetic protocol for chromosome preparation. The average TL per telomere was significantly
increased in hTERT-expressing cells compared with that in vector
control cells (Table 1; Fig. 2A–C). We also noticed a significant
decrease in TLV across all chromosomal ends (Table 1) and a
significant decrease in the frequency of excessively long telomeres
(average 2.6 per cell in vector controls vs. 1.6 per cell in hTERTexpressing cells, P = 0.005). This observation prompted us to
examine if changes in TL at each chromosomal end in hTERTexpressing cells were correlated with the TL of the corresponding
chromosomal end in vector control cells. Surprisingly, we found
a strong inverse correlation between the TL in vector control
cells and the percentage TL change in hTERT-expressing cells
(Pearson correlation coefficient [r] = -0.80, P < 0.001; Fig. 2A).
More importantly, the data indicated that telomere length at the
chromosomal end possessing the longest telomere (10 q) was

PD6 to PD48, whereas the number of excessively long telomeres
remained stably low, and the number of very short telomeres
decreased from PD6 to PD48 (Table 2). The observed small
TLV and low number of excessively long and very short telomeres
in GUMC001 cells are comparable with what was observed in
hTERT-expressing IMR90 cells (Table 1). In contrast, IMR90

©2014 Landes Bioscience. Do not distribute.

non-tumorigenic.15 This culture condition dramatically upregulates endogenous hTERT expression level (8- to 14-fold increase)
and telomerase activity.15 Under the feeder layer co-culture
condition, GUMC001 cells (human primary prostate epithelia cells) maintained relatively small and constant TLV and no
significant change in average telomere length per telomere from

Figure 2. Expression of hTERT shortens long telomeres and elongates short telomeres in human primary fibroblasts. Expression of hTERT in human
primary fibroblasts IMR90 and WI38 shortened long telomeres and elongated short telomeres. Metaphase spreads were prepared and hybridized with
a Cy3 (red) telomere PNA probe and FITC (green) label chromosome specific centromere probes. Figure 1A and D show correlations between the average TL at specific chromosomal ends in vector control cells and percents of TL change at the corresponding chromosomal ends in hTERT-overexpressing
cells. Each dot represents a chromosomal end. Thirty cells were analyzed per cell line. Representative metaphase images were displayed. (B) IMR90vector, (C) IMR90-hTERT, (E) WI38-vector, (F) WI38-hTERT.
www.landesbioscience.com
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for another telomerase-positive fibrosarcoma cell line, HT1080
(Table 2). Our data indicates that knockdown hTERT in telomerase-positive cancer cell lines affects telomere elongation and
results in shorter telomeres across all chromosomal ends.
The enzymatic domain of hTERT is required for hTERTmediated telomere shortening
To investigate the role of telomerase activity in hTERT-mediated telomere shortening, we used a haemagglutinin (HA)-tagged
hTERT mutant construct in which the aspartic acid and valine
residues at positions 710 and 711 in the third reverse transcriptase
motif of hTERT were substituted with alanine and isoleucine,
respectively.16 This mutant construct lacks telomerase activity
(enzymatically dead) and has a dominate-negative effect on telomere elongation. Consistent with previous reports,16,17 no telomerase activity was detected in HA immunoprecipitates after the
mutant construct was expressed (Fig. S1). Expressing this mutant
hTERT in U2OS cells did not affect average TL per telomere and
TLV (Table 3; Fig. 1C). We observed no significant change in
TL on both Xp (long telomere) and Xq (short telomere; Table 3;
Fig. 1C). These data suggest that the catalytic domain of hTERT
is required for shortening the excessively long telomeres.
Expressing the mutant hTERT in SAOS2 cells induced a
significant decrease in average TL per telomere and increase in
TLV. The increase in TLV in cells expressing the mutant hTERT
was primarily driven by significant increases in the frequency of
very short telomeres (average 10.6 per cell in vector control cells

Table 3. Effect of expressing hTERT-mutant, hTR and hTERT on telomere length
Cell line, passage #

Telomerase
activity*

RNA fold
change*

Avg_TL overall

TLV

Xp

Xq

U2OS-vector, p4

1

1

7779 ± 1348

73.0 ± 7.3

11379 ± 5128

3573 ± 4859

U2OS-hTERT-Mutant, p4

1

8

7459 ± 1529

72.1 ± 7.2

12140 ± 7725

3199 ± 4292

0.45

0.52

0.58

0.76

P value

Avg_TL chromosome specific

11p

11q

SAOS2-vector, p4

1

1

1175 ± 224

111.0 ± 25.0

1122 ± 1191

11051 ± 5585

SAOS2-hTERT-Mutant, p4

1

9

820 ± 196

179.8 ± 60.0

533 ± 478

14296 ± 7476

<0.001

<0.001

0.016

0.06

P value

Xp

Xq

U2OS-vector, p4

1

1

5313 ± 751

83.5 ± 6.0

6872 ± 3812

553 ± 675

U2OS-hTR, p4

4

8

6454 ± 383

79.5 ± 10.5

8006 ± 5521

2967 ± 3720

<0.001

0.08

0.38

0.002

P value

11p

11q

SAOS2-vector, p4

1

1

1531 ± 250

102.6 ± 19.6

1719 ± 1385

12809 ± 5405

SAOS2-hTR, p4

3

7

1356 ± 298

109.3 ± 23.0

1785 ± 2248

11138 ± 5664

0.02

0.24

0.89

0.25

P value
WI-38 VA13-vector, p4

1

1

5841 ± 1955

90.1 ± 11.2

ND

ND

WI-38 VA13-hTERT, p4

6

7

3407 ± 1169

96.2 ± 7.5

ND

ND

<0.001

0.017

P value

#
Passage after hTERT-mutant or hTR or hTERT or empty vector transfection. *Telomerase activity and hTR mRNA fold change relative to vector control.
Avg_TL is the average telomere length in fluorescence intensity units. TLV, telomere length variation (CV%). Mean ± SD were reported values in the table.
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(human primary fibroblast cells) cultured in conventional condition resulted in rapid loss of telomere length and significantly
increased TLV from PD10 to PD60. The number of excessively
long telomeres also showed a significant trend of increase (P for
trend < 0.001, Table 2). IMR90 cells grown in conventional cell
culture condition typically have very low levels of hTERT expression and telomerase activity (Table 2). These data suggest that
upregulation of endogenous hTERT in prostate epithelial cells
may have shortened excessively long telomeres and elongated
short telomeres to maintain a small TLV, which is consistent
with the results obtained by ectopically overexpressing hTERT
in human primary fibroblast cells. Because GUMC001 does not
grow in conventional cell culture conditions without feeder layer,
we could not obtain chromosome preparations without hTERT
upregulation to show a direct comparison.
hTERT knockdown in telomerase-positive cancer cells
decreases the telomere length
To investigate the effects of downregulation of hTERT on
telomere length in telomerase-positive cancer cells, we used
siRNA to knockdown hTERT in MDA231, a breast cancer cell
line. hTERT knockdown efficiency was confirmed by TRAP
assay and qRT-PCR. Downregulation of hTERT significantly
decreased average telomere length per telomere and increased
TLV in MDA231 cells. The increase in TLV is accompanied
by increases in the frequency of very short telomeres and excessively long telomeres (Table 2). Similar results were obtained

©2014 Landes Bioscience. Do not distribute.
Figure 3. TPP1 physically and functionally interacts with hTERT to regulate telomere length. (A) Depletion of TPP1 by shRNA. Lentiviral empty vector or
TPP1 shRNAs were expressed in SAOS2 cells. Protein expression was analyzed by western blotting with indicated antibodies. (B) Effects of depletion of
TPP1 on telomere length. hTERT was expressed in ALT+ SAOS2 cells with or without expression of TPP1 shRNA. Thirty cells were analyzed per cell line. (C)
Representative metaphase images of SAOS2 cell with or without shTPP1 and/or hTERT expression. Amplified chromosome 11 was shown in the upper
right corner. (D) TPP1 binds to hTERT in SAOS2 cells by coimmunoprecipitation. Nuclear extracts (0.5 mg) were treated with DNase I and then subjected
to immunoprecipitation with the anti-Flag (TPP1) antibody, followed by western blotting with indicated antibodies. IgG was used as a control. Fifty
micrograms of nuclear extract was loaded as input. (E) Recombinant TPP1 recruits hTERT binding to the telomere DNA substrate. The biotin-D-loop DNA
was incubated with in vitro-translated HA-hTERT in the absence or presence of various amounts of recombinant TPP1 (5 and 20 nmol). The biotinylated
DNA substrate and its bound proteins on the beads were analyzed by SDS-PAGE gel. Quantitative data is from 3 independent experiments (mean ± S.D.).
Bovine serum albumin did not affect TPP1-enhanced hTERT binding to the D-loop substrate. HA-hTERT was detected by WB with the anti-HA antibody.
Input, 50% of the total HA-hTERT used in each reaction. (F) hTERT generates t-circle formation, and TPP1 is required for hTERT-mediated t-circles. Empty
vector and hTERT were expressed in ALT+ SAOS2 cells with or without expression of shTPP1, and 2D assay was performed to detect t-circle formation.
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significantly increased the binding of HA-hTERT to the telomeric DNA substrates in a dose-dependent manner (Fig. 3E).
Bovine serum albumin did not affect the telomere DNA binding
activity of HA-hTERT. These data indicate that TPP1 dramatically enhances hTERT binding to the telomeric DNA substrates.
hTERT-mediated telomere shortening increases t-circle
formation
T-circle formation has been shown to involve the telomere
recombination mechanism,13,24-26 and the increase in t-circles
in ALT+ cells is considered a by-product of removed long telomeres.11 Expression of hTERT in SAOS2 cells increased t-circles as measured by the 2D gel assay (Fig. 3F). The increase
in hTERT-induced t-circles was also confirmed in primary
human fibroblasts (IMR90) by overexpression of hTERT (data
not shown). Further, we found that TPP1 depletion prevented
hTERT-induced t-circle formation in SOAS2 cells (Fig. 3F),
consistent with our T-FISH findings that hTERT overexpression failed to shorten long telomeres on 11q in TPP1-depleted
SAOS2 cells (Fig. 3B and C). Together, these data suggest that
telomere recombination is likely involved in hTERT-mediated
telomere shortening, and TPP1 might regulate the hTERT loading on telomeres for telomere recombination during the hTERTmediated telomere-shortening process.
hTERT-mediated telomere shortening does not induce telomere signal-free ends and telomere dysfunction
We found that overexpression of hTERT did not increase the
number of telomere signal-free chromosomal ends by T-FISH
analysis, nor did it induce telomere dysfunctional foci formation
(Fig. S5), which is consistent with previous reports.24,25 In fact,
expression of hTERT reduced the number of telomere signal-free
ends in all the cell lines tested. Our observations are in agreement
with previous reports that overexpression of hTERT in human
primary cells leads to continued cell growth and extended life
span in the absence of a DNA damage response.1,27-29 These data
suggest that hTERT-mediated telomere shortening does not
produce telomere-free chromosomal ends and is different from
aberrant rapid telomere deletion, which triggers a DNA damage
response and ultimately initiates cell cycle arrest.

Discussion
In the present study, we demonstrated that telomerase enzymatic component hTERT plays an important role in maintaining the upper limit of telomere length by shortening excessively
long telomeres in human primary and cancer cells. Our results
revealed a novel mechanism, which involves hTERT, possibly
TPP1, and telomere homologous recombination (HR) to shorten
the excessively long telomeres. hTERT-mediated telomere shortening induces t-circle formation that has been show to involve
telomere HR process. Telomere HR has been demonstrated to
takes place during the G2 /M phase of the cell cycle, after DNA
synthesis.9 Thus hTERT-mediated telomere shortening is likely
to occur during G2 /M phase of cell cycle (post-telomere synthesis). Additionally, hTERT-mediated telomere shortening does
not require the telomerase RNA component, hTR, indicating
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vs. 16.3 per cell in hTERT-mutant expressing cells, P < 0.001)
(Table 3). While short telomeres (i.e., 11p) had significantly
decreased TL (−52%, P = 0.02), in contrast, excessively long telomere on 11q had slightly increased TL (+29%, Table 3; Fig. 1G),
confirming that this mutant hTERT failed to shorten excessively
long telomeres. Together, our data indicated that the enzymatic
domain is required for hTERT-mediated telomere shortening.
hTR is not required for hTERT-mediated telomere
shortening
Previous reports showed that overexpression of hTR increased
telomerase activity and elongated telomere length.11 To examine
the effect of hTR on telomere shortening, we expressed hTR in
U2OS and SAOS2 cells. The function of hTR construct was first
tested by expressing it in HT1080, and hTR expression resulted
in 8- and 6-fold increase in hTR mRNA level and telomerase
activity, respectively, consistent with previous reports.11,12
Expressing hTR in U2OS cells significantly increased average
TL per telomere and borderline significantly decreased TLV, due
to a decrease in the frequency of very short telomeres. Although
hTR expression significantly increased telomere length on short
telomeres (Xq, +436%), it had no significant effect on the length
of the long telomeres on Xp (Table 3; Fig. 1D). Expressing hTR
in SAOS2 cells did not shorten the telomere length on chromosome 11q (Table 3; Fig. 1H), although hTR mRNA levels
increased 6–8-fold (Fig. S1). These data indicate that overexpression of hTR alone does not shorten long telomeric DNA.
To further confirm whether hTR is required for hTERTmediated telomere shortening, we expressed wide-type hTERT
in a hTR-negative cancer cell line, WI38 VA13. T-FISH analysis
revealed that expression hTERT dramatically shortened average
telomere length per telomere and decreased frequency of excessively long telomeres from an average of 20 per cell in vector controls cells to 6 per cell in hTERT expression cells (P < 0.001,
Table 3; Fig. 1I and J), indicating that hTR is not required in
hTERT-mediated telomere shortening.
TPP1 is required for hTERT-mediated telomere shortening
TPP1 is a shelterin protein and interacts with telomerase for
telomere elongation.18-23 We examined its role on hTERT-mediated
telomere shortening. TPP1 knockdown did not affect average TL
in SAOS2 (P = 0.72) and had no significant effect on the length
of very long telomeres on 11q (Fig. 3A–C). In TPP1-depleted
SAOS2 cells, overexpressing hTERT significantly increased average TL per telomere (P < 0.001) and had no significant effect
on TLV (P = 0.14). Analysis of chromosome-specific TL revealed
that expression of hTERT did not shorten long telomeres on 11q
in TPP1-depleted SAOS2 cells (Fig. 3B and C), suggesting that
hTERT-mediated telomere shortening requires TPP1.
Using immunoprecipitation assays, we found that Flag-TPP1
co-precipitated with HA-hTERT (Fig. 3D). Treatment with
DNase-I did not prevent the TPP1–hTERT interaction, excluding bridging effects of nucleic acids. We then tested whether
recombinant TPP1 regulates the binding of HA-hTERT to
telomere DNA. Immunoblot analysis with anti-HA antibody
showed that, in the absence of TPP1, HA-hTERT was associated with biotinylated-telomeric DNA substrates that were
retrieved by streptavidin beads (Fig. 3E). The addition of TPP1
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endonuclease that could play a role in hTERT-mediated telomere
shortening is the TERRA complex. TERRA promotes telomere
shortening through exonuclease 1-meidated resection of chromosome ends.37 Other human telomerase-associated nucleases might
also associate with hTERT-mediated telomere shortening.24,25,38
Future studies will determine whether these factors are required
for hTERT-mediated telomere-shortening process.
Our data indicated that the enzymatic domain of hTERT is
needed for hTERT-mediated telomere shortening. But depletion
of hTR did not affect hTERT-mediated telomere shortening, suggesting that direct hTERT reverse transcriptase function may not
be required for the telomere-shortening process. Recruitment of
hTERT onto telomeres depends on its binding partners and telomeric DNA status.34,39,40 It is possible that the enzymatic domain
of hTERT is required for protein–protein interactions involved in
one or multiple steps in hTERT-mediated telomere shortening,
such as hTERT recruitment onto telomeric DNA, an initiated
sensor for telomere length “counting” and/or regulation of endonucleases. The mutation in the enzymatic domain of hTERT may
have altered its protein surface structure to lose the binding ability. A recent paper reported that a translocation-defective telomerase with low levels of activity and processivity stabilizes short
telomeres and confers immortalization.41 These data support the
notion that the different hTERT functional domains could associate with hTERT-mediated telomere length shortening.
Gradual telomere attrition and telomere trimming have been
implicated in telomere length shortening.2-4,10-12 The hTERTmediated telomere-shortening process is distinct from telomere
attrition. It is well known that telomere attrition is the result of
the end-replication problem.42-44 Telomere attrition, induced by
successive cell division, occurs on all telomeres, including very
short telomeres and leads to loss of telomere protection that
triggers a DNA damage response and ultimately induces cell
cycle arrest.10 In contrast, hTERT-mediated telomere shortening only shortens excessively long telomeres and does not trigger
a DNA damage response. It removes excessive telomeric DNA
to maintain the telomere length equilibrium (near the average
telomere length) at the processed chromosomal ends. It is likely
that hTERT-mediated telomere shortening is part of the routine
telomere post-synthesis processing and critical to maintain upper
telomere length limit in human cells, since it exists in several
human primary cells and cancer cell lines.
Telomere trimming induced by overexpression of hTR is the
HR-mediated resolution of the terminal t-loop structure.11,12
hTERT-mediated telomere shortening may share the same processing factors to generate t-circles as telomere trimming. It is
currently unknown whether hTERT participates in the initiation of “telomere trimming”, since the entire process of “telomere
trimming” is not well defined, and the factor(s) that triggers the
“telomere trimming” remains to be identified. Our data indicates that hTR is not required for hTERT-mediated telomere
shortening, suggesting that the mechanism may be different
from “telomere trimming”. In addition, hTERT-mediated telomere shortening significantly decreases telomere length variation
across all chromosomal ends, while telomere trimming induces
long and heterogeneous telomere lengths in the cells.11,12
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that the role of hTERT in telomere shortening is mechanistically
distinct from its involvement in telomere elongation. We further
demonstrated that telomere shelterin protein, TPP1, is required
for hTERT-mediated t-circle formation and telomere shortening, supporting the TPP1-hTERT-telomere HR-based model to
shorten long telomeres in human cells.
Telomere length in normal human cells is tightly regulated
within a narrow range, and its regulatory system is complex. The
best-known mechanism to counteract telomere attrition is the
enzyme telomerase, a reverse transcriptase complex that contains
hTERT and hTR. Telomerase elongates telomeres by adding
TTAGGG repeats to the ends of chromosomes.2-4 In contrast,
very little is known about how cells maintain the upper limit
of telomere length. Our data indicate that hTERT plays a central role in maintaining the upper limit of telomere length by
shortening the excessively long telomeres in human cells. hTERT
regulates telomere length homeostasis by shortening long telomeres and elongating short telomeres, and these 2 opposing
but biologically interactive functions appear to be regulated by
local factors, such as telomere length at a specific chromosomal
end, and are likely to involve telomere length counting as illustrated in budding yeast, in which Rif1 and Rif2 were proposed
molecules to be counted for length determination, and Rap1, a
telomere binding protein, recruits Rif proteins to the telomeric
track.30,31 The mechanism underlying the telomere length counting in human cells is largely unknown. Our data indicated that
TPP1, a member of shelterin protein complex, is required in the
hTERT-mediated telomere-shortening process. It is possible that
shelterin protein binding initiates telomere length “counting”
in human cells. TPP1 recruits hTERT onto telomeres to recognize the length set-point for shortening, or the TPP1–hTERT
complex may act as effectors to recruit HR proteins, which
carry out the reaction to remove excessive telomeric DNA at the
long telomeres, and this process generates t-circles. Our observation that expressing hTERT in human fibroblasts and ALT+
cancer cells significantly increased amount of t-circles suggests
that HR is involved in hTERT-mediated telomere shortening.
HR-mediated resolution of t-loops can result in loss of telomeric
DNA equivalent to the length of the t-loop and can generate
extrachromosomal t-circles.13 This process depends on the HR
proteins XRCC3 and MRN complex, which have been implicated in resolvase activity. ATM plays a critical role in maintenance of telomeres and may also be involved in this telomere
metabolism process.32-35 T-circles are prevalent in cells utilizing
the ALT mechanism and are also found in telomerase-positive
cancer cell lines following progressive telomere lengthening by
exogenous telomerase activity.11
hTERT-mediated telomere shortening might require endonucleases. A recent paper has shown that SLX4 assembles with a
telomere maintenance toolkit by bridging multiple endonucleases
with telomeres.36 SLX4 interacts with endonucleases SLX1, XPF,
and MUS81 and also interacts with telomeric protein TRF2. It
negatively regulates telomere length through SLX1-catalyzed
nucleolytic resolution of telomeric DNA structures. However,
whether SLX4 protein complex is involved in hTERT-mediated
telomere shortening remains to be illustrated. Another candidate

Materials and Methods
Cell culture, western blot analyses, and immunoprecipitation assays
ALT cell lines U2OS, SAOS-2, WI-35-VA13, and non-ALT
cell lines MCF7, HT1080, IMR90, and WI38 cells were cultured
in respective mediums (Clontech). Western blotting analyses and
immunoprecipitation were essentially as described previously.57
Ectopical expression of hTERT, lentiviral shRNA constructs, and antibodies
The lentiviral HA-tagged hTERT construct was transfected
into 293T cells. After 48 h, supernatant media with virus were
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collected. When an equal titer of supernatant from hTERT construct or a vector control was transduced into different cell lines,
almost all the cells became puromycin resistant, showing high
transduction efficiency in the experimental system. After 48 h
of infection with hTERT vector, hTERT mRNA and protein
expressions were examined.
hTERT and TPP1 shRNAs were designed and cloned to the
lentiviral vector (Sigma) (shRNA sequences are available upon
request). The following antibodies were used: anti-mouse HA
(abCAM) and anti-rabbit Flag (Sigma).
Measurement of chromosome-specific telomere length by
fluorescent in situ hybridization
Chromosome arm-specific telomere length was measured
by telomere quantitative fluorescent in situ hybridization
(TQ-FISH) as previously described.14 Briefly, chromosome preparations were dropped onto clean microscopic slides and hybridized with 15 μl of hybridization mixture consisting of 0.3 μg/ml
Cy3-labeled telomere-specific peptide nucleic acid (PNA) probe,
1 μl of cocktails of FITC-labeled centromeric PNA probes specific for chromosomes 2, 4, 8, 9, 13, 15, 18, 20, and 21, and
20 μg/ml of Cy3-labeled centromeric PNA probes specific for
chromosome X (Biomarkers), in hybridization buffer containing
50% formamide, 10 mM TRIS-HCl, pH 7.5, and 5% blocking
reagent. Slides were denatured and then hybridized at 30 °C for
3 h. After hybridization, the slides were sequentially washed 10
min each at 42 °C: once in 1 × SSC, once in 0.5 × SSC, and once
in 0.1 × SSC. The slides were then mounted in anti-fade mounting medium containing 300 ng/ml DAPI.
After TQ-FISH, cells were analyzed using an epifluorescence
microscope equipped with a charge-coupled device (CCD) camera. Metaphase cells were captured with exposure times of 0.15,
0.25, and 0.05 s for Cy3, FITC, and DAPI signals, respectively.
Digitized metaphase images were analyzed using the Isis software (MetaSystems Inc), which permits the measurement of 92
telomere signals simultaneously after karyotyping. Telomere
fluorescent intensity units (FIU) were recorded as an indirect
measurement of telomere length. For each study subject, 30
metaphase cells were analyzed.
Immunofluorescence and in combination with telomeric
DNA-FISH assays
Cells were cultured on 4-well chamber slides, and immunofluorescence staining was performed after pre-extract in 0.5%
Triton/PBS for 1 min on ice, as described previously.58 To combine with telomeric DNA-FISH, after immunostaining, slides
were fixed, treated with 0.5 μg/ml RNase A in 2 × SSC for 45
min at 37 °C, and then dehydrated in 70%, 80%, and 100%
ethanol. After being denatured at 80 °C for 3 min, slides were
hybridized for 2 h in hybridization solution contained 0.3 μg/ml
Tel-C PNA telomere probe (Applied Biosystems) with 70% formamide, 1% BSA, and 10 mM Tris, pH 7.2. Finally, slides were
washed, dehydrated, and covered with anti-fading 4’-6-diamidino-2-phenylindole (DAPI) mounting medium.
2D gel assays and TRF assays
Genomic DNA was isolated following standard procedure59
and digested with Hinf I. Samples were separated by electrophoresis on 0.5% agarose gel at 1 v/cm for 18–20 h. For the TRF
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Most human somatic cells have little or no telomerase to prevent telomere loss; in such a situation, successive cell divisions lead
to progressive telomere attrition due to the end-replication problem.42-44 Critically short telomeres trigger cellular growth arrest
that drives progressive atrophy and functional decline in highturnover tissues.45,46 Thus, progressive telomere loss was proposed
to be the basis of cellular senescence and aging.47 On the other
hand, telomere-associated replicative senescence is regarded as an
important tumor-suppressive mechanism.48 While the detrimental effects of short telomeres on human health have been intensively studied, very little is known about the health consequences
of excessively long telomeres. If only short telomeres are deleterious to cells, why aren’t telomere lengths in human cells longer
in order to buffer the telomere attrition, and why do telomerasepositive cancer cells predominantly maintain substantially shorter
telomeres?49-51 Perhaps excessively long telomeres are simply more
costly to maintain, leading to reduced fitness in cell production
to replenish high-turnover tissues and affecting human longevity.
Excessively long telomeres may cause disruption of proper telomere-capping functions, including t-loop formation and associated telomere-binding proteins, leading to harmful consequences
such as chromosome instability. Excessively long telomeres are
vulnerable to replication slippage, stalled replication forks, or the
formation of secondary structures that disturb normal cell cycle
progression. In these regards, shortening excessively long telomeres
is likely to be equally important as elongating very short telomeres
for proper cell proliferation and efficient cell production.
Given the importance of telomere biology in cancer and other
aging-associated diseases,52-55 targeted manipulation of telomere
maintenance mechanisms not only provides a promising strategy
for treating cancer and aging-associated diseases, but, in certain circumstances, may also be useful for the prevention of aging-related
health conditions. Unveiling the dual regulatory roles of hTERT
in maintaining telomere length homeostasis adds a new element
to the current molecular model of telomere length maintenance.
Telomerase is regarded as a promising target for cancer therapy,
and the treatment efficacy of telomerase inhibition has been shown
to be related to telomere length in the tumor cells.56 Our discovery
reminds us of the ever complex role of telomerase in the regulation
of telomere length and other critical cellular functions and adds
a new domain to be considered when designing drugs that target
telomerase for cancer therapy and disease prevention.
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